E
TEVA icon

Ergoteles’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Ergoteles’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-49,814
Closed -$375K – 758
2023
Q2 		$375K Sell
49,814
-27,850
-36% -$226K 0.02% 714
2023
Q1 		$687K Buy
+77,664
New +$768K 0.03% 628
2021
Q3 		– Sell
-201,589
Closed -$2M – 1654
2021
Q2 		$2M Buy
201,589
+52,362
+35% +$554K 0.05% 364
2021
Q1 		$1.72M Buy
+149,227
New +$1.71M 0.05% 301

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Ion Asset Management
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Slate Path Capital
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
Rubric Capital Management (New York)
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Ergoteles's TEVA Position: Q3 2023 in Review

Ergoteles sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2023, closing a stake of 49,814 shares — an estimated $375K sold.

Ergoteles first reported a position in TEVA in Q1 2021 and held it in 4 quarters. The position peaked at $2M in Q2 2021. 436 funds tracked by Wall St. Rank hold TEVA as of Q3 2023.

  • Ergoteles reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 49,814 Teva Pharmaceutical Industries Limited shares in Q3 2023, an estimated $375K.
  • Ergoteles first reported a position in Teva Pharmaceutical Industries Limited in Q1 2021 and held it in 4 quarters.
  • Ergoteles's Teva Pharmaceutical Industries Limited position peaked at $2M in Q2 2021.
  • 436 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.